Andrew T Yang

Quadriga BioSciences, Inc. is a privately-held pharmaceutical company developing proprietary targeted cancer therapies. Our technology is based on the discovery that many aggressive forms of cancer cells over-express certain unique amino acid transporters on their cell surfaces for the intake of nutrients to support rapid tumor growth and proliferation. Exploiting this biology, Quadriga is developing novel targeted molecules against cancer cells that over-express these transporters. Our mission is to develop safer and more effective treatments for patients with cancer.

Most businesses today depend on digital platforms — and the data they generate — for their growth and competitive edge. With timely, accessible, trustworthy data, you always know how you’re doing in digital and are ready to explore new ideas and business opportunities. Yet that data ecosystem is getting harder to manage. Without automating your data workflows, your data team will quickly be overwhelmed and your business teams will be left waiting for answers. Few companies can hire data engineers at the pace at which their digital strategies must evolve. Our mission is to do the complex integration and data engineering work that create trustworthy data so our customers can stay focused on growing their revenue.

Berkeley Lights is now part of Bruker Cellular Analysis

Protein Metrics vendor-neutral software allows scientists to use data generated on analytical instruments like mass spectrometers to quickly identify and report protein sequences as well as any variations from the expected form. We innovate so that biopharmaceutical companies and university research labs can achieve confident results from their analysis and reporting. With our customers, we are boldly advancing protein characterization. For more information, visit http://www.proteinmetrics.com.

Quadriga BioSciences, Inc. is a privately-held pharmaceutical company developing proprietary targeted cancer therapies. Our technology is based on the discovery that many aggressive forms of cancer cells over-express certain unique amino acid transporters on their cell surfaces for the intake of nutrients to support rapid tumor growth and proliferation. Exploiting this biology, Quadriga is developing novel targeted molecules against cancer cells that over-express these transporters. Our mission is to develop safer and more effective treatments for patients with cancer.

Most businesses today depend on digital platforms — and the data they generate — for their growth and competitive edge. With timely, accessible, trustworthy data, you always know how you’re doing in digital and are ready to explore new ideas and business opportunities. Yet that data ecosystem is getting harder to manage. Without automating your data workflows, your data team will quickly be overwhelmed and your business teams will be left waiting for answers. Few companies can hire data engineers at the pace at which their digital strategies must evolve. Our mission is to do the complex integration and data engineering work that create trustworthy data so our customers can stay focused on growing their revenue.

Berkeley Lights is now part of Bruker Cellular Analysis

Protein Metrics vendor-neutral software allows scientists to use data generated on analytical instruments like mass spectrometers to quickly identify and report protein sequences as well as any variations from the expected form. We innovate so that biopharmaceutical companies and university research labs can achieve confident results from their analysis and reporting. With our customers, we are boldly advancing protein characterization. For more information, visit http://www.proteinmetrics.com.